Cardiologists have found a way to cool the human heart in a localized way to help reduce muscle damage from heart attacks. 

A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?

The genomics arm of the National Institutes of Health has pledged a total of $280 million for research into the genetic bases of disease.

Genetic variants that cripple a triglyceride-producing protein are linked with a lower risk of heart attack and stroke.

In the latest iteration of organ-on-a-chip technology, researchers develop an in vitro model of functioning human heart tissue with an inherited cardiovascular disease.

A report reveals that using bone marrow stem cells to treat heart disease is less promising than a decade of research has let on.

Nanoscale agents that detect disease-associated synthetic biomarkers in urine could one day streamline the diagnosis of tumors, heart disease, and more.

A genetic mapping study of intestinal bacteria shows that people with fewer and less diverse bacteria are at greater risk of obesity and associated diseases.

From cardiovascular problems to neurological disorders, a plethora of new medical devices are reducing the need for surgery and improving the quality and safety of healthcare.